Stericycle (SRCL) Tops Q4 EPS by 8c, FY EPS Guidance Misses

Stericycle (NASDAQ: SRCL) reported Q4 EPS of $1.03, $0.08 better than the analyst estimate of $0.95. Revenue for the quarter came in at $852.7 million versus the consensus estimate of $849.97 million.

GUIDANCE:

Stericycle sees FY2019 EPS of $3.32-$3.72, versus the consensus of $4.20. Stericycle sees FY2019 revenue of $3.408-3.533 billion, versus the consensus of $3.49 billion.

For earnings history and earnings-related data on Stericycle (SRCL) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal
• Nike names former Pfizer CFO David Denton as new finance chief